| Report ID | 281664 |
| Drug Identification Number | 02487020 |
| Brand name | ENGERIX-B |
| Common or Proper name | Hepatitis B vaccine (recombinant) |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1s |
| Anatomical Therapeutical Chemical (ATC) code | J07BC |
| Anatomical Therapeutical Chemical (ATC) description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2026-03-23 |
| Estimated end date | 2026-04-30 |
| Actual end date | 2026-04-14 |
| Shortage status | Resolved |
| Updated date | 2026-04-15 |
| Company comments | Supply available for public programs. Supply unavailable in the private market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-04-15 | French | Compare |
| v3 | 2026-04-15 | English | Compare |
| v2 | 2026-03-27 | French | Compare |
| v1 | 2026-03-27 | English | Compare |
Showing 1 to 4 of 4